Feature: Big pharmaceutical companies exposed for theft, high prices
This background suggests that Harris’ issues with Novartis should be taken very seriously by the US government.
By Emmanuel Koro
Jul. 24, 2023
Premium
Tshabangu’s backing of ED2030 backfires
News
By Miriam Mangwaya and Nqobani Ndlovu
Jan. 12, 2025
Premium
The mysterious millions that Wicknell Chivayo threw away in spending spree revealed
News
Jan. 12, 2025